Clinical Trial Update: A Phase I Study of HW201877 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of HW201877 in healthy participants, with inflammatory bowel disease noted as a condition, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• HW201877

Snippet

Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company | Conditions: Healthy Participants, IBD (Inflammatory Bowel Disease) | Phase 1 | Status: RECRUITING